iANTHUS CAPITAL HOLDINGS (ITHUF) Shares Outstanding (Diluted Average) (2021 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Shares Outstanding (Diluted Average) came in at $7.0 billion in Q1 2026, up 3.38% year-on-year from $6.7 billion in Q1 2025, and up 3.92% quarter-over-quarter from $6.7 billion in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $7.0 billion for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $7.0 billion, up 3.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 billion (up 3.38% YoY), and the FY2025 annual result was $6.7 billion, up 2.49% from the prior year.
- Shares Outstanding (Diluted Average) came in at $7.0 billion for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $6.7 billion in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $7.0 billion in Q1 2026 to a low of $3.4 million in Q4 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $6.5 billion (2024), against an average of $4.5 billion.
- Across the five-year window, Shares Outstanding (Diluted Average) surged 1369402.91% in 2022 and slumped 98.88% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Shares Outstanding (Diluted Average) stood at $3.4 million in 2022, then surged by 190834.72% to $6.4 billion in 2023, then grew by 1.59% to $6.5 billion in 2024, then advanced by 2.49% to $6.7 billion in 2025, then climbed by 3.92% to $7.0 billion in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $7.0 billion (Q1 2026), $6.7 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 6.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.96 Bn |
| Dec 31, 2025 | 6.70 Bn |
| Sep 30, 2025 | 6.70 Bn |
| Jun 30, 2025 | 6.75 Bn |
| Mar 31, 2025 | 6.74 Bn |
| Dec 31, 2024 | 6.54 Bn |
| Sep 30, 2024 | 6.54 Bn |
| Jun 30, 2024 | 6.54 Bn |
| Mar 31, 2024 | 6.57 Bn |
| Dec 31, 2023 | 6.44 Bn |
| Sep 30, 2023 | 6.43 Bn |
| Jun 30, 2023 | 6.41 Mn |
| Mar 31, 2023 | 6.42 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 2.35 Bn |
| Jun 30, 2022 | 572.11 Mn |
| Mar 31, 2022 | 171.72 Mn |
| Dec 31, 2021 | 171,718.00 |
| Sep 30, 2021 | 171,718.00 |
| Jun 30, 2021 | 171,643.00 |